Literature DB >> 310310

Lack of correlation between in vivo rejection of syngeneic fibrosarcomas and in vitro non-specific macrophage cytotoxicity.

R Evans, C G Booth, F Spencer.   

Abstract

Two transplantable, highly immunogenic syngeneic C57BL fibrosarcomas, FS1 and FS6, were shown to have tumour-specific rejection antigens, as shown by excision of the primary tumours and i.p. or i.m. injection of graded doses of the specific and unrelated tumour cells. I.p. challenge with tumour cells induced a large and relatively long-lasting increase in numbers of peritoneal leucocytes. Macrophage monolayers prepared from such exudates were, in general, non-specifically cytotoxic, though occasional specific cytotoxicity was detected. T lymphocytes isolated from exudates were shown to kill in a specific manner. When immunized mice were challenged with the specific tumour cells to elicit large numbers of peritoneal cytotoxic cells, and with graded doses of the non-cross-reacting tumour cells at the same time or at various times thereafter, growth of the non-related tumours occurred in all cases and only the specific tumour was rejected. Moreover, Winn tests, in which the inflammatory cells were mixed with unrelated tumour cells and implanted i.m., did not delay tumour growth. The relevance of these findings to the role of macrophages and lymphocytes in syngeneic tumour rejection is discussed.

Entities:  

Mesh:

Year:  1978        PMID: 310310      PMCID: PMC2009787          DOI: 10.1038/bjc.1978.253

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  11 in total

1.  Tumor-graft rejection in syngeneic guinea pigs: evidence for a two-step mechanism.

Authors:  B Zbar; H T Wepsic; T Borsos; H J Rapp
Journal:  J Natl Cancer Inst       Date:  1970-02       Impact factor: 13.506

2.  Differential survival of solid tumor cells after inoculation into established ascites tumors.

Authors:  E KLEIN; G KLEIN
Journal:  Cancer Res       Date:  1954-02       Impact factor: 12.701

3.  BCG immunotherapy of rat tumours in athymic nude mice.

Authors:  M V Pimm; R W Baldwin
Journal:  Nature       Date:  1975-03-06       Impact factor: 49.962

4.  Mechanism of immunologically specific killing of tumour cells by macrophages.

Authors:  R Evans; P Alexander
Journal:  Nature       Date:  1972-03-24       Impact factor: 49.962

5.  Neoantigens on spontaneous and carcinogen-induced rat tumors defined by in vitro lymphocytotoxicity assays.

Authors:  R W Baldwin; M J Embleton
Journal:  Int J Cancer       Date:  1974-04-15       Impact factor: 7.396

6.  Induction of macrophage-mediated tumor-cell cytotoxicity by pyran copolymer.

Authors:  A M Kaplan; P S Morahan; W Regelson
Journal:  J Natl Cancer Inst       Date:  1974-06       Impact factor: 13.506

7.  Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity.

Authors:  R Evans; P Alexander
Journal:  Immunology       Date:  1972-10       Impact factor: 7.397

Review 8.  Cell-mediated cytotoxicity, allograft rejection, and tumor immunity.

Authors:  J C Cerottini; K T Brunner
Journal:  Adv Immunol       Date:  1974       Impact factor: 3.543

9.  Serologic evidence for cross-reacting antigens in two carcinogen-induced murine sarcomas.

Authors:  D Fritze; D H Kern; S R Waldman; Y H Pilch
Journal:  Int J Cancer       Date:  1975-01-15       Impact factor: 7.396

10.  Further analysis of the anti-tumour effect in vitro of peritoneal exudate cells from mice treated with Corynebacterium parvum.

Authors:  A Ghaffar; R T Cullen; M A Woodruff
Journal:  Br J Cancer       Date:  1975-01       Impact factor: 7.640

View more
  7 in total

Review 1.  Macrophages: progress and problems.

Authors:  D S Nelson
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

Review 2.  Macrophages and neoplasms: new insights and their implication in tumor immunobiology.

Authors:  R Evans
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

3.  Specific tumoricidal activity of cytotoxic macrophages and cytotoxic lymphocytes.

Authors:  H F Dullens; S Schakenraad; A Oostdijk; W Vuist; M Van der Maas; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

4.  I. Tumor growth in mice with depressed capacity to mount inflammatory responses: possible role of macrophages.

Authors:  M Nelson; D S Nelson; K E Hopper
Journal:  Am J Pathol       Date:  1981-08       Impact factor: 4.307

5.  The immunological mouse mutants nude (nu) and rhino (hrrh) generate cytotoxic effector cells following adoptive immunotherapy but fail to reject a transplanted tumor.

Authors:  R Evans; T M Duffy; L D Shultz
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

6.  Tumour-derived lymphoid cells prevent tumour growth in Winn assays.

Authors:  R A Robins; G R Flannery; R W Baldwin
Journal:  Br J Cancer       Date:  1979-12       Impact factor: 7.640

7.  Differential sensitivity of two murine leukaemia sublines to cytolysis by Corynebacterium parvum-activated macrophages.

Authors:  D Berd; M J Mastrangelo
Journal:  Br J Cancer       Date:  1981-12       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.